Literature DB >> 5738374

In vivo effects of the synalbumin insulin antagonist.

L Kammerer, J Vallance-Owen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5738374     DOI: 10.1007/bf01211768

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  16 in total

1.  EFFECT OF THE INSULIN-INHIBITORY ALBUMIN FRACTION FROM NORMAL AND DIABETIC SUBJECTS ON ADIPOSE TISSUE.

Authors:  H ALP; L RECANT
Journal:  Metabolism       Date:  1964-07       Impact factor: 8.694

2.  SYNALBUMIN INSULIN ANTAGONISM.

Authors:  J VALLANCE-OWEN
Journal:  Diabetes       Date:  1964 May-Jun       Impact factor: 9.461

3.  STUDIES OF THE INSULIN-INHIBITORY EFFECT OF HUMAN ALBUMIN FRACTIONS.

Authors:  H ALP; L RECANT
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

4.  Antagonism of insulin by albumin.

Authors:  C LOWY; G BLANSHARD; D PHEAR
Journal:  Lancet       Date:  1961-04-15       Impact factor: 79.321

5.  The determination of serum albumin and globulin by a new method.

Authors:  J R DEBRO; H TARVER; A KORNER
Journal:  J Lab Clin Med       Date:  1957-11

6.  Insulin antagonism in plasma of diabetic patients and normal subjects.

Authors:  J VALLANCE-OWEN; E DENNES; P N CAMPBELL
Journal:  Lancet       Date:  1958-08-16       Impact factor: 79.321

7.  Estimation of plasma-insulin by the rat diaphragm method.

Authors:  J VALLANCE-OWEN; B HURLOCK
Journal:  Lancet       Date:  1954-01-09       Impact factor: 79.321

8.  Failure of synalbumin to exhibit insulin antagonism in vivo.

Authors:  M B Davidson; C J Goodner
Journal:  Diabetes       Date:  1967-06       Impact factor: 9.461

9.  Partial purification of an insulin inhibitor from human albumin fractions.

Authors:  H Alp; H Chaplin; L Recant
Journal:  J Clin Endocrinol Metab       Date:  1966-03       Impact factor: 5.958

10.  The Vallance-Owen ("synalbumin") insulin antagonist. Reproducibility and reliability of results in nondiabetic and diabetic humans.

Authors:  L Sherman
Journal:  Diabetes       Date:  1966-03       Impact factor: 9.461

View more
  4 in total

1.  Effects of the synalbumin insulin antagonist in vivo; its examination with a new method.

Authors:  L Kammerer; M Bretán; O Steingaszner
Journal:  Diabetologia       Date:  1970-10       Impact factor: 10.122

2.  [Synalbumin insulin antagonism in northern India].

Authors:  J S Bajaj; D D Bansal; S K Gupta
Journal:  Acta Diabetol Lat       Date:  1971 Mar-Apr

3.  Further studies on the incidence of the synalbumin insulin antagonist.

Authors:  J S Bajaj; D McMaster; J Vallance-Owen
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

4.  Variations in synalbumin insulin antagonism during tolbutamide tolerance test.

Authors:  J S Bajaj; J Vallance-Owen
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.